VRTX Vertex Pharmaceuticals Incorporated
VRTX Vertex Pharmaceuticals Incorporated
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 2 scans as of 2026-10-16 2 bull converging
POC $432.61 · VWAP $469.02 · +11.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
2 related campaigns
VRTX Price Structure
Loading timeframes…
Peers
Every watchlist VRTX belongs to, members best 30-day change first — VRTX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech
@healthcare-scan
@healthcare
@ibb
@biotech-scan
@insider-universe
Reported the quarter ending 2026-06-30: revenue $3.33B, diluted EPS $4.31, net income $1.10B (SEC filing). Across the print the stock moved +0.3% (close before → first close after).
full note →Against street estimates
How VRTX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about VRTX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 15 days ago · Oct 8
- Vertex Pharmaceuticals price target raised to $576 from $570 at RBC Capital | Markets Insider
- Vertex to Acquire Crinetics Pharmaceuticals | Vertex ...
- Vertex Pharmaceuticals Stock Price | VRTX Stock Quote, News, and History | Markets Insider
- Vertex Reports Second Quarter 2026 Financial Results – Company Announcement - FT.com
- Vertex Reports Second Quarter 2026 Financial Results
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
VRTX research tape
160 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.